Over Priced Drug
- All
- News
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
"Donald, I Beg You": Trump Mocks France's Emmanuel Macron Over Tariffs
US President Donald Trump mocked his French counterpart, Emmanuel Macron, in a rare impression, recounting how he coerced Paris into agreeing to triple its drug prices by threatening to hike tariffs on all French imports to America.
-
Risk Of STDs, Unplanned Pregnancies As China Imposes Tax On Condoms
China will soon start collecting a value-added tax on contraceptive drugs and products for the first time in over three decades, a move aligned with Beijing's effort to get families to have more children after decades of limiting most to one child.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
New "Vaccine-Like" HIV Drug Could Cost 1,000 Times Less Than Current Price
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
-
Sweden Forced to Pay Jailed Drug Dealer Over $1.5 Million in Bitcoin: Find Out Why
In a recent ruling, Sweden's government is being forced to pay more than $1.5 Million (roughly Rs. 11 crores) to a drug dealer who was jailed in 2019 after the Bitcoin he had illegally amassed appreciated while he was in custody. Read all about it here.
-
Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months.
-
Expected Rise In Drug Prices Post-GST Create Panic
The expected rise in drug prices post-GST has created chaos among the customers who are in dire need of life-surviving drugs. With uncertainty over tax slabs, pharma companies are in complete disorder.
-
US Consumers Will Want Donald Trump, Congress To Take On Drug Prices
Americans' growing alarm over rising prescription drug costs will pressure a new US administration and Congress to take action on pharmaceutical pricing, industry executives and healthcare experts say.
-
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
With spiralling costs of medicines becoming a major concern for the common man, the government now plans to bring down the prices of 108 drugs.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
"Donald, I Beg You": Trump Mocks France's Emmanuel Macron Over Tariffs
US President Donald Trump mocked his French counterpart, Emmanuel Macron, in a rare impression, recounting how he coerced Paris into agreeing to triple its drug prices by threatening to hike tariffs on all French imports to America.
-
Risk Of STDs, Unplanned Pregnancies As China Imposes Tax On Condoms
China will soon start collecting a value-added tax on contraceptive drugs and products for the first time in over three decades, a move aligned with Beijing's effort to get families to have more children after decades of limiting most to one child.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
New "Vaccine-Like" HIV Drug Could Cost 1,000 Times Less Than Current Price
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
-
Sweden Forced to Pay Jailed Drug Dealer Over $1.5 Million in Bitcoin: Find Out Why
In a recent ruling, Sweden's government is being forced to pay more than $1.5 Million (roughly Rs. 11 crores) to a drug dealer who was jailed in 2019 after the Bitcoin he had illegally amassed appreciated while he was in custody. Read all about it here.
-
Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months.
-
Expected Rise In Drug Prices Post-GST Create Panic
The expected rise in drug prices post-GST has created chaos among the customers who are in dire need of life-surviving drugs. With uncertainty over tax slabs, pharma companies are in complete disorder.
-
US Consumers Will Want Donald Trump, Congress To Take On Drug Prices
Americans' growing alarm over rising prescription drug costs will pressure a new US administration and Congress to take action on pharmaceutical pricing, industry executives and healthcare experts say.
-
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
With spiralling costs of medicines becoming a major concern for the common man, the government now plans to bring down the prices of 108 drugs.
